BURONI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.928
EU - Europa 1.323
AS - Asia 860
OC - Oceania 13
AF - Africa 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.135
Nazione #
US - Stati Uniti d'America 1.909
CN - Cina 797
IE - Irlanda 488
UA - Ucraina 206
FI - Finlandia 169
DE - Germania 137
IT - Italia 126
SE - Svezia 89
GB - Regno Unito 53
SG - Singapore 28
CA - Canada 18
FR - Francia 16
JO - Giordania 14
BE - Belgio 13
AU - Australia 11
RU - Federazione Russa 7
IN - India 5
JP - Giappone 4
MU - Mauritius 4
PL - Polonia 4
CZ - Repubblica Ceca 3
ES - Italia 3
GR - Grecia 3
BR - Brasile 2
CL - Cile 2
EU - Europa 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
TR - Turchia 2
VN - Vietnam 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
GS - Georgia del Sud e Isole Sandwich Australi 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.135
Città #
Chandler 488
Dublin 480
Jacksonville 256
Nanjing 194
Ashburn 167
Beijing 144
Boardman 135
Princeton 80
Lawrence 75
Helsinki 74
Nanchang 68
Wilmington 67
Medford 64
Ann Arbor 63
Jiaxing 63
Shenyang 59
Hebei 53
Pavia 52
Shanghai 52
Changsha 50
Hangzhou 41
Tianjin 31
New York 22
Woodbridge 22
Milan 18
Singapore 17
Norwalk 15
Amman 13
Los Angeles 13
Brussels 12
Verona 12
Ottawa 11
Falls Church 10
Fairfield 9
Washington 9
Redwood City 8
Houston 7
Piscataway 7
San Francisco 7
Des Moines 6
Seattle 6
Rome 5
Toronto 5
Auburn Hills 4
Chicago 4
Dearborn 4
Tokyo 4
Warsaw 4
Adelaide 3
Cambridge 3
Falkenstein 3
Gunzenhausen 3
Melbourne 3
Ningbo 3
Olomouc 3
Perth 3
Pune 3
Rockville 3
Tappahannock 3
Verrua Po 3
Bangkok 2
Brisbane 2
Buffalo 2
Cinisello Balsamo 2
Da Nang 2
Florence 2
Fuzhou 2
Guangzhou 2
Jinan 2
Kemerovo 2
Las Vegas 2
Madrid 2
San Genesio ed Uniti 2
St Petersburg 2
Taizhou 2
Wuhan 2
Amsterdam 1
Auckland 1
Baku 1
Baoding 1
Beiyuan 1
Bishkek 1
Borås 1
Bratislava 1
Bruges 1
Chifeng 1
Dallas 1
Dhaka 1
Dundas 1
Eskişehir 1
Esslingen am Neckar 1
Fayetteville 1
Focsani 1
Frankfurt am Main 1
Fremont 1
Guntur 1
Harbin 1
Hengshui 1
Huntington 1
Hyderabad 1
Totale 3.102
Nome #
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 85
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 84
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 83
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 83
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 81
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 80
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 78
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 77
A census of RND superfamily proteins in the Burkholderia genus. 76
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 75
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 75
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 75
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 73
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 72
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 72
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 71
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 71
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 70
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 70
Mycobacterium tuberculosis: drug resistance and future perspectives 70
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 68
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 68
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 68
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 67
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 66
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 65
Identification of the cellular target of the potential antitubercular drug BM 212 64
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 64
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 63
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 62
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 62
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 61
Molecular basis for antibiotic resistance in the genus Burkholderia 61
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 61
Antistaphylococcal activity of the ftsz inhibitor c109 61
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 60
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 59
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 58
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 58
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 56
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 55
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 54
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 53
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 52
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 52
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 51
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 49
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 49
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 46
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 46
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 45
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 44
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 44
Antivirulence compounds: a future direction to overcome antibiotic resistance? 44
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 43
Mycobacterium tuberculosis efflux pumps: an update 41
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 40
Quorum sensing as antivirulence target in cystic fibrosis pathogens 39
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 38
A new promising bactericidal compound against Burkholderia cenocepacia. 38
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 38
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 37
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 35
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 35
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 35
The role of RND efflux transporters in Burkholderia cenocepacia life. 34
Methodological tools to study species of the genus Burkholderia 34
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 30
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 28
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 28
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 27
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 27
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 27
Recent advances to combat ESKAPE pathogens with special reference to essential oils 25
AI is a viable alternative to high throughput screening: a 318-target study 25
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 22
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 19
Editorial: Insights Into New Strategies to Combat Biofilms 18
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 17
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 14
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 13
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 11
Editorial: Community series in insights into new strategies to combat biofilms, volume II 7
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 5
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 5
Totale 4.292
Categoria #
all - tutte 17.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020376 0 0 0 48 5 41 12 61 6 109 88 6
2020/2021473 51 41 14 40 13 53 1 103 28 60 56 13
2021/2022362 7 5 1 17 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/2025152 23 101 28 0 0 0 0 0 0 0 0 0
Totale 4.292